Clinical Trial

Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 27, 2022 (before its estimated November 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate relationships between multiparametric imaging biomarkers and genetic analysis in glioblastoma patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-09-12.
Status change: Enrolling by Invitation → Not Yet Recruiting 2022-09-25
Trial Details
NCT Number NCT05541042
Lead Sponsor Henan Provincial People's Hospital
Conditions Glioblastoma
Enrollment 50 participants
Start Date 2022-12-01
Primary Completion 2025-11-01 (estimated)
Study Completion 2027-11-01 (estimated)
Updated on ClinicalTrials.gov 2022-09-27